Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
POSSIBLE Mobile was a premier digital agency specializing in the design and development of high-performance mobile applications for iOS and Android. Founded in 2008 as DoubleEncore and later acquired by WPP, the firm became a key partner for life science and healthcare companies seeking digital transformation. They developed sophisticated mHealth solutions for clients such as GlaxoSmithKline (GSK) and LifeScan, focusing on patient engagement and clinical trial data collection. Their expertise included building HIPAA-compliant software and integrating mobile sensors for real-world evidence gathering. In 2019, the agency was merged into Wunderman Thompson, and it is now part of the global VML network. The company's legacy remains centered on its contribution to the early adoption of mobile technology in regulated healthcare environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on POSSIBLE Mobile.